R1 RCM Holdco Inc
F:6HL0
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.1
13.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
R1 RCM Holdco Inc
R1 RCM Holdco Inc
Total Liabilities & Equity
R1 RCM Holdco Inc
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
R1 RCM Holdco Inc
F:6HL0
|
Total Liabilities & Equity
$5.7B
|
CAGR 3-Years
57%
|
CAGR 5-Years
45%
|
CAGR 10-Years
28%
|
|
|
DaVita Inc
NYSE:DVA
|
Total Liabilities & Equity
$17.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Total Liabilities & Equity
$16.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
|
CVS Health Corp
NYSE:CVS
|
Total Liabilities & Equity
$252.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
13%
|
|
|
Cigna Corp
NYSE:CI
|
Total Liabilities & Equity
$157.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
11%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Total Liabilities & Equity
$18.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
10%
|
|
R1 RCM Holdco Inc
Glance View
R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. The company is headquartered in Murray, Utah and currently employs 27,200 full-time employees. The company went IPO on 2010-05-20. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also improving patient, physician, and staff satisfaction for its customers. Its primary service offering consists of RCM services for health systems, hospitals, and physician groups. The company also offers modular services, allowing customers to engage for only specific components of its end-to-end RCM service offering, such as physician advisory services (PAS), practice management (PM), revenue integrity solutions (RIS), patient experience (PX), coding management, and business office services. Its PAS offering assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes.
See Also
What is R1 RCM Holdco Inc's Total Liabilities & Equity?
Total Liabilities & Equity
5.7B
USD
Based on the financial report for Sep 30, 2024, R1 RCM Holdco Inc's Total Liabilities & Equity amounts to 5.7B USD.
What is R1 RCM Holdco Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
28%
Over the last year, the Total Liabilities & Equity growth was 14%. The average annual Total Liabilities & Equity growth rates for R1 RCM Holdco Inc have been 57% over the past three years , 45% over the past five years , and 28% over the past ten years .
You don't have any saved screeners yet
